Edward Espinosa v. HHS - Tdap, Guillain-Barré syndrome (2021)

On August 12, 2020, Edward Espinosa filed a Vaccine Program petition after receiving a tetanus-diphtheria-acellular pertussis (Tdap) vaccine on June 19, 2018. He alleged that the Tdap vaccination caused Guillain-Barre Syndrome.

The public decision was entered on a joint stipulation and contains limited clinical detail. It identifies the vaccine, date, and alleged GBS, but it does not describe onset, neurologic testing, treatment, or expert analysis.

Respondent denied that the Tdap vaccine caused Espinosa's alleged GBS or any other injury, and denied that his current condition was a sequela of a vaccine-related injury. The stipulation was therefore a negotiated resolution rather than a concession of causation.

The parties filed a stipulation on December 21, 2021. Special Master Katherine E.

Oler reviewed the file, found the stipulation reasonable, and adopted it that day. Espinosa was awarded a lump sum of $83,291.00, payable to him, representing all damages available under section 15(a).

The clerk was directed to enter judgment under the stipulation. Espinosa was represented by Jessica Olins of Maglio Christopher & Toale, P.A.